You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Article info

Article menu
Clinical and epidemiological research
Extended report
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Authors

  • Louise K Mercer Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Johan Askling Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Pauline Raaschou Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • William G Dixon Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Lene Dreyer Department of Rheumatology, Herlev and Gentofte University Hospital, Hellerup, Denmark The Parker Institute, Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Merete Lund Hetland The DANBIO registry and Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup and second affiliation Hetland: Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Anja Strangfeld Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany PubMed articlesGoogle scholar articles
  • Angela Zink Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany Charité University Medicine Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Xavier Mariette Rheumatology Department, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Axel Finckh Rheumatology Division, University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Helena Canhao Rheumatology Research Unit, Rheumatology Department, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon Portugal, CHLN- Santa Maria Hospital, CAML, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Florenzo Iannone Rheumatology Unit—DIM, University of Bari, Bari, Italy PubMed articlesGoogle scholar articles
  • Jakub Zavada Institute of Rheumatology, Prague, Czech Republic First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Jacques Morel Department of Rheumatology, Teaching Hospital of Lapeyronie and University of Montpellier, Montpellier, France PubMed articlesGoogle scholar articles
  • Jacques-Eric Gottenberg Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, CNRS, Institut de Biologie Moléculaire et Cellulaire, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Kimme L Hyrich Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust and University of Manchester Partnership, Manchester, UK PubMed articlesGoogle scholar articles
  • Joachim Listing Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joachim Listing, Deutsches Rheuma-Forschungszentrum Berlin, Ein Leibniz Institut, Programmbereich Epidemiologie, Charitéplatz 1, Berlin 10117, Germany; Listing{at}drfz.de
View Full Text

Citation

Mercer LK, Askling J, Raaschou P, et al
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Annals of the Rheumatic Diseases 2017;76:386-391.

Publication history

  • Received January 28, 2016
  • Revised May 19, 2016
  • Accepted May 27, 2016
  • First published June 15, 2016.
Online issue publication 
April 20, 2023

Article Versions

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/